Dr. Ping Li is a European and German patent attorney. Ping has extensive experience in representing international clients before the European Patent Office (EPO), the Unified Patent Court (UPC), the German Federal Patent Court, and German district courts in patent grant, opposition, revocation, and infringement proceedings. Her work covers all aspects of patent prosecution, including drafting, examination, opposition, and appeal proceedings at the EPO. She has worked on numerous invalidity and infringement matters and is experienced in conducting IP due diligence and freedom-to-operate analyses, as well as providing patent validity opinions and advice on supplementary protection certificates (SPCs). Ping represents international clients across the United States, Europe, and Asia in all fields of technology, including biotechnology; life science; lithium-ion battery technology; organic, inorganic, and polymer chemistry; materials chemistry; renewable energy; biofuel production; nanotechnology, adhesive, and paper technology; as well as computer-implemented inventions.
Ping is a synthetic and biophysical chemist by training, with technical experience spanning various areas of chemistry, including organic and inorganic synthesis, NMR (nuclear magnetic resonance) spectroscopy, mass spectrometry, electron microscopy, and radioactive labelling. Her doctoral research at the Max Planck Institute for Biophysical Chemistry in Göttingen led to several peer-reviewed publications, including a first-author publication in the journal Science in 2007. Drawing on her extensive scientific background, Ping brings a deep understanding of inventions across a wide range of technological fields.
Ping is a member of the Institute of Professional Representatives before the European Patent Office (epi), the German Patent Bar Association, the International Federation of Intellectual Property Attorneys, and the German Association for the Protection of Intellectual Property (GRUR).
担当案件
- December 13, 2021
Women in IP Speaker Series: Artificial Intelligence in the Biopharma Lifecycle: U.S. and EU IP Considerations - June 6, 2019
Successful claim strategies for inventions arising from product development and emerging technologies: US v. EP, AbbVie IP Day 2019 - September 16, 2015
Opposition Proceedings at the EPO Webinar
- European Litigation Certificate (2024); European Qualifying Examination (2013); German Patent Bar Exam (2013); Georg-August-University Göttingen and Max Planck Institute for Biophysical Chemistry, Göttingen, Germany (Dr. rer. nat. with summa cum laude for thesis 2007); University of Canterbury, Christchurch, New Zealand (B.Sc. in Chemistry with first class honors 2002); Uppsala University, Sweden (exchange student in chemistry, 2001)
- Unified Patent Court (UPC), European Patent Office (EPO), German Patent and Trademark Office (GPTO), German Federal Patent Court (BPatG), German Federal Supreme Court (BGH) in nullity appeal proceedings, German Federal Office for Plant Varieties (BSA), International Bureau of WIPO (IB), Office for Harmonization in the Internal Market (OHIM, European Community Trademarks and Designs)
- Internship with the District Court of Mannheim, German Patent and Trademark Office, and German Federal Patent Court (2012-2013)
- Mandarin Chinese, English, and German